Sources: Stanford University professor James Zou aims to raise ~$100M at a ~$1B valuation for Human Intelligence, which aims to use AI to study physiology (Rebecca Torrence/Bloomberg)

A Stanford professor is raising $100M to launch Human Intelligence, a startup applying AI to physiological research, signaling enterprise AI's expansion into life sciences and healthcare—a domain with significant regulatory, competitive, and talent acquisition implications for technology organizations. This capital raise reflects investor confidence in AI-driven scientific discovery, which will likely accelerate demand for specialized AI infrastructure, compliance expertise, and partnerships between IT organizations and life sciences divisions. CIOs should anticipate increased investment in secure, regulated AI environments and prepare for talent competition as biotech and healthcare sectors aggressively pursue advanced AI capabilities.